The patients in the Phase III trial is initially in one of two treatment groups.

This press release contains forward-looking statements that involve various risks and uncertainties that could cause actual results to differ materially from those described. Cause such a difference cause such differences include, but are not limited to, uncertainties relating to our ability to successfully completed Phase III clinical trials and secure regulatory approval of our current or future drug-delivery system and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors and others from time to time from time to time in our filings with the Securities and Exchange Commission. You should place undue reliance on these forward -looking statements which speak only as of the day they are made.

Scientists hope that the mapping of the various networks may one day enable them to predict where a small perturbation most damage, which could eventually provide valuable information could do for drug design.. If they disturbed M. Pneumoniae tweak tweak proteins, Bork and his colleagues also found that disasters will not necessarily occur. As in our own cells, proteins in this bacterium rarely alone. They interact with each other, cooperate or perform different steps in chain reactions.The award is is one of three out of to the NSF of EUR of $ 14,000 the scientists particular at UCLA, Stanford, UC Davis, Texas A & M, Michigan State University said Scripps Research Institute, study below hide unanswered questions unanswered questions at the to investigate biologie excellent.